Cargando…
Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
SIMPLE SUMMARY: T-cell lymphomas are a rare, heterogeneous family of lymphomas derived from post-thymic T lymphocytes. For patients with relapsed or refractory disease, outcomes are generally poor, with overall survival usually less than one year in the absence of an allogeneic hematopoietic stem ce...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913081/ https://www.ncbi.nlm.nih.gov/pubmed/36765544 http://dx.doi.org/10.3390/cancers15030589 |